10th Edition of
World Congress on Infectious Diseases & One Health
October 05-07, 2026 | Tokyo, Japan
Mumps is a viral infection caused by the mumps virus, a member of the Paramyxoviridae family. The virus primarily targets the salivary glands, leading to characteristic swelling and inflammation. Mumps is highly contagious and spreads through respiratory droplets or direct contact with saliva from an infected person. Clinical features of mumps include the swelling of one or more salivary glands, typically the parotid glands located on the sides of the face. This swelling gives affected individuals a characteristic "chipmunk cheek" appearance. Other symptoms include fever, headache, muscle aches, and fatigue. Mumps infections are usually self-limiting, with recovery occurring within a couple of weeks. Complications of mumps can include orchitis (inflammation of the testicles) in males, which may lead to infertility in rare cases. Mumps can also cause meningitis and encephalitis, although these complications are less common. The Mumps-Measles-Rubella (MMR) vaccine has been highly effective in preventing mumps and its complications.
Title : Molecular crosstalk between the host and pathogen in Streptococcus pyogenes virulence
Francis J Castellino, University of Notre Dame, United States
Title : Phenotypic characterisation of non tuberculous mycobacterium species isolated from clinical specimens
Anant Marathe, Parul Institute of Medical Sciences and Research, Parul University, India
Title : Praziquantel for the treatment of preschool-aged children with schistosomiasis: Results of an RCT
Susannah Colt, Warren Alpert Medical School of Brown University, United States
Title : Carbapenemase-producing multidrug resistance of gram negative bacilli causing bacteremia at the general hospital of Mexico during the Covid-19 pandemic
Silvia Giono, Instituto Politecnico Nacional, Mexico
Title : The largest histamine poisoning outbreak in Brazil: An experience report from a one health perspective in Fernando de Noronha
Camila Ferro, Fundacao Oswaldo Cruz (Fiocruz), Brazil
Title : Combating antimicrobial resistance in sub-Saharan Africa: Advancing one health strategies for sustainable infectious disease control
Ugorji Miracle Enyinnaya, Greatlink Pharmaceutical, Nigeria